DEPOSITS OF IMMUNOGLOBULINS AND COMPLEMENT IN SKIN OF PATIENTS WITH RHEUMATOID-ARTHRITIS - INFLUENCE OF ANTI-RHEUMATIC TREATMENT

被引：20
|
作者：
ULLMAN, S
HOIERMADSEN, M
HALBERG, P
JANS, H
SYLVEST, J
机构：
[1] HVIDOVRE HOSP,DEPT MED,RHEUMATOL SECT,DK-2650 HVIDOVRE,DENMARK
[2] HVIDOVRE HOSP,BLOOD BANK,DK-2650 HVIDOVRE,DENMARK
[3] FREDERIKSBERG HOSP,DEPT REHABIL & PHYS MED,DK-2000 COPENHAGEN,DENMARK
[4] STATE SERUM INST,DEPT BLOOD GRP,AUTOIMMUNE LAB,COPENHAGEN,DENMARK
来源：
SCANDINAVIAN JOURNAL OF RHEUMATOLOGY | 1979年 / 8卷 / 02期
关键词：
D O I：
10.3109/03009747909105349
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：119 / 123
页数：5
相关论文
共 50 条
  • [41] Change in cardiovascular risk after initiation of anti-rheumatic treatment in early rheumatoid arthritis
    Turk, S. A.
    Heslinga, M.
    Twisk, J.
    van der Lugt, V.
    Lems, W. F.
    van Schaardenburg, D.
    Nurmohamed, M. T.
    CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 2019, 37 (03) : 513 - 513
  • [42] The Effects of Periodontal Treatment on Rheumatoid Arthritis and of Anti-Rheumatic Drugs on Periodontitis: A Systematic Review
    Inchingolo, Francesco
    Inchingolo, Angelo Michele
    Avantario, Pasquale
    Settanni, Vito
    Fatone, Maria Celeste
    Piras, Fabio
    Di Venere, Daniela
    Inchingolo, Alessio Danilo
    Palermo, Andrea
    Dipalma, Gianna
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2023, 24 (24)
  • [43] LONAZOLAC-CA - A NON STEROIDAL ANTI-RHEUMATIC DRUG - CLINICAL LONGTERM STUDY IN RHEUMATOID-ARTHRITIS
    LONAUER, G
    WAGNER, H
    BOERNGEN, U
    GOEBEL, KM
    ZEITSCHRIFT FUR RHEUMATOLOGIE, 1981, 40 (04): : 161 - 164
  • [44] SERUM ANTI-IMMUNOGLOBULINS IN PSORIATIC ARTHRITIS AS COMPARED WITH RHEUMATOID-ARTHRITIS
    TAPANES, FJ
    RAWSON, AJ
    HOLLANDER, JL
    ARTHRITIS AND RHEUMATISM, 1972, 15 (02): : 153 - +
  • [45] Anti-rheumatic treatment is not associated with reduction of pentraxin 3 in rheumatoid arthritis, psoriatic arthritis and ankylosing spondylitis
    Deyab, Gia
    Hokstad, Ingrid
    Whist, Jon Elling
    Smastuen, Milada Cvancarova
    Agewall, Stefan
    Lyberg, Torstein
    Bottazzi, Barbara
    Meroni, Pier Luigi
    Leone, Roberto
    Hjeltnes, Gunnbjorg
    Hollan, Ivana
    PLOS ONE, 2017, 12 (02):
  • [46] DOUBLE-BLIND STUDY WITH A NEW ANTI-RHEUMATIC DRUG SULINDAC IN TREATMENT OF RHEUMATOID-ARTHRITIS - COMPARISON WITH ACETYLSALICYLIC-ACID
    CARUSO, I
    FUMAGALLI, M
    TIRRITO, M
    MONTRONE, F
    VERNAZZA, M
    CARRATELLI, L
    SERIO, A
    EUROPEAN JOURNAL OF RHEUMATOLOGY AND INFLAMMATION, 1978, 1 (01) : 58 - 65
  • [47] Heart Failure Risk Among Patients with Rheumatoid Arthritis: Association with Anti-Rheumatic Drugs
    Ahlers, Michael
    Stein, C. Michael
    Chung, Cecilia P.
    Ormseth, Michelle J.
    Farber-Eger, Eric
    Gupta, Deepak
    ARTHRITIS & RHEUMATOLOGY, 2018, 70
  • [48] Predictors of Non-Adherence with Anti-Rheumatic Medication in Rheumatoid Arthritis Patients: Data from a Rheumatoid Arthritis Cohort
    Ahluwalia, Vandana
    Movahedi, Mohammad
    Rampakakis, Emmanouil
    Cesta, Angela
    Li, Xiuying
    Sampalis, John S.
    Bombardiers, Claire
    ARTHRITIS & RHEUMATOLOGY, 2016, 68
  • [49] ADHERENCE TO BIOLOGIC AND CONVENTIONAL DISEASE MODIFYING ANTI-RHEUMATIC DRUGS IN PATIENTS WITH RHEUMATOID ARTHRITIS
    Mishra, P.
    VALUE IN HEALTH, 2018, 21 : S198 - S198
  • [50] Retention rates of disease-modifying anti-rheumatic drugs in patients with rheumatoid arthritis
    Agarwal, S.
    Zaman, T.
    Handa, R.
    SINGAPORE MEDICAL JOURNAL, 2009, 50 (07) : 686 - 692
12345